HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.

Abstract
Alzheimer's disease (AD), the most common age-related neurodegenerative disorder, is characterized by the invariant cerebral accumulation of β-amyloid peptide. This event occurs early in the disease process. In humans, [18F]-fluoro-2-deoxy-D-glucose ([18F]-FDG) positron emission tomography (PET) is largely used to follow-up in vivo cerebral glucose utilization (CGU) and brain metabolism modifications associated with the Alzheimer's disease pathology. Here, [18F]-FDG positron emission tomography was used to study age-related changes of cerebral glucose utilization under resting conditions in 3-, 6-, and 12-month-old APP(SweLon)/PS1(M146L), a mouse model of amyloidosis. We showed an age-dependent increase of glucose uptake in several brain regions of APP/PS1 mice but not in control animals and a higher [18F]-FDG uptake in the cortex and the hippocampus of 12-month-old APP/PS1 mice as compared with age-matched control mice. We then developed a method of 3-D microscopic autoradiography to evaluate glucose uptake at the level of amyloid plaques and showed an increased glucose uptake close to the plaques rather than in amyloid-free cerebral tissues. These data suggest a macroscopic and microscopic reorganization of glucose uptake in relation to cerebral amyloidosis.
AuthorsGéraldine Poisnel, Anne-Sophie Hérard, Nadine El Tannir El Tayara, Emmanuel Bourrin, Andreas Volk, Frank Kober, Benoit Delatour, Thierry Delzescaux, Thomas Debeir, Thomas Rooney, Jésus Benavides, Philippe Hantraye, Marc Dhenain
JournalNeurobiology of aging (Neurobiol Aging) Vol. 33 Issue 9 Pg. 1995-2005 (Sep 2012) ISSN: 1558-1497 [Electronic] United States
PMID22079157 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Aif1 protein, mouse
  • Amyloid beta-Protein Precursor
  • Calcium-Binding Proteins
  • Glial Fibrillary Acidic Protein
  • Microfilament Proteins
  • PSEN1 protein, human
  • Presenilin-1
  • Fluorodeoxyglucose F18
  • Glucose
Topics
  • Alzheimer Disease (diagnostic imaging, genetics, pathology)
  • Amyloid beta-Protein Precursor (genetics)
  • Analysis of Variance
  • Animals
  • Calcium-Binding Proteins (metabolism)
  • Cerebral Cortex (diagnostic imaging, metabolism, pathology)
  • Cerebrovascular Circulation (genetics, physiology)
  • Disease Models, Animal
  • Fluorodeoxyglucose F18
  • Glial Fibrillary Acidic Protein (metabolism)
  • Glucose (metabolism)
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microfilament Proteins (metabolism)
  • Positron-Emission Tomography
  • Presenilin-1 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: